Martin Mendoza, PhD, serves as the director of Health Equity for the All of Us (AoU) Research Program at the National Institutes of Health (NIH). In this role, Dr. Mendoza provides leadership and high-level expertise on improving inclusion and equity in precision medicine and addressing health equity issues for the AoU Research Program.
Prior to joining AoU, Dr. Mendoza served as director of the Division of Policy and Data (DPD) at the Office of Minority Health (OMH) in the Office of the Secretary at the U.S. Department of Health and Human Services (HHS). In this capacity, Dr. Mendoza provided oversight, leadership, and direction to DPD’s role in developing health policies and initiatives that are designed to address the elimination of health disparities and advance health equity.
Previous to OMH, Dr. Mendoza was the lead for extramural research for the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the US Food and Drug Administration (FDA), overseeing the OMHHE extramural research portfolio as part of the FDA Centers of Excellence in Regulatory Science and Innovation (CERSI) program. Dr. Mendoza has testified before Congress in support of OMHHE’s programs and mission and has been an invited speaker at numerous scientific/industry meetings and workshops. He is the primary author for OMHHE’s pivotal FDA guidance document “Collection of Race and Ethnicity Data in Clinical Trials” and is a recognized global expert in clinical trial diversity.
Before FDA, Dr. Mendoza served in the Division of Clinical Research at the National Institute of Neurological Disorders and Stroke (NINDS) at NIH. There, he was part of programmatic management for all extramural NINDS-sponsored clinical trials, worked to evaluate human subjects protections for these trials, and oversaw the institute’s Congressionally-mandated reporting of women and minorities in clinical research.
Preceding NINDS, Dr. Mendoza was an active researcher within the NIH Intramural Research Program. He conducted his primary laboratory-based research training in the Pediatric Oncology Branch at the National Cancer Institute and served as a genetic mapper for the Human Genome Project at the National Human Genome Research Institute.
Dr. Mendoza is a graduate of the University of Maryland Baltimore County and received his doctorate in cancer biology from the Johns Hopkins University.